158 related articles for article (PubMed ID: 29748583)
1. Screening for the anti-inflammation quality markers of Xiaojin Pills based on HPLC-MS/MS method, COX-2 inhibition test and protein interaction network.
Xiong X; He YN; Feng B; Pan Y; Zhang HZ; Ke XM; Zhang Y; Yang M; Han L; Zhang DK
Sci Rep; 2018 May; 8(1):7454. PubMed ID: 29748583
[TBL] [Abstract][Full Text] [Related]
2. Comparative study on the pharmacodynamic difference of oral administration of Xiaojin Pills accompanied with Chinese Baijiu and water.
Song J; Feng B; Zhang D; Qiu M; Ran F; Cao B; Xu H; Lin J; Xu R; Han L
J Ethnopharmacol; 2021 Oct; 278():114284. PubMed ID: 34111538
[TBL] [Abstract][Full Text] [Related]
3. Comparative and mechanistic study of pharmacodynamic difference in anti-breast cancer activity between water and liquor extracts of Xiaojin Pills.
Liu H; Cao B; Li C; Han L; Xu H; Lin J; Zhang D; Xu R
J Ethnopharmacol; 2022 Jun; 291():115104. PubMed ID: 35218896
[TBL] [Abstract][Full Text] [Related]
4. [Systematic review and comment on modern study of Xiaojin Pills].
Xiong X; Feng B; Cao B; Zhang DK; Xiong KP; Lin JZ; Ci ZM; Xu RC; Han L
Zhongguo Zhong Yao Za Zhi; 2018 Dec; 43(24):4801-4807. PubMed ID: 30717523
[TBL] [Abstract][Full Text] [Related]
5. Analysis of the pharmacodynamic difference between Xiaojin Pills taken with Chinese Baijiu and water based on serum pharmacochemistry and pharmacokinetics.
Song J; Liao W; Deng X; Zhang D; Lin J; Xu R; Han L
J Ethnopharmacol; 2023 Jan; 300():115723. PubMed ID: 36115600
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms exploration of Xiaojin Pills on lung cancer based on metabolomics and network pharmacology.
Cao B; Lin J; Wu Z; Liu H; Zhang D; Xu H; Xu R; Han L
J Pharm Pharmacol; 2021 Jul; 73(8):1071-1079. PubMed ID: 33864464
[TBL] [Abstract][Full Text] [Related]
7. Identification of NF-κB inhibitors in Qishenyiqi dropping pills for myocardial infarction treatment based on bioactivity-integrated UPLC-Q/TOF MS.
Han Y; Zhou M; Xing L; Jiang M; Bai G; Luo G
Biomed Chromatogr; 2015 Oct; 29(10):1612-8. PubMed ID: 25845699
[TBL] [Abstract][Full Text] [Related]
8. Bioactivity fingerprint analysis of cyclooxygenase-2 ligands from radix Aconiti by ultrafiltration-UPLC-MSn.
Zhu H; Liu S; Li X; Song F; Liu Z; Liu S
Anal Bioanal Chem; 2013 Sep; 405(23):7437-45. PubMed ID: 23831827
[TBL] [Abstract][Full Text] [Related]
9. Screening for anti-proliferative and anti-inflammatory components from Rhamnus davurica Pall. using bio-affinity ultrafiltration with multiple drug targets.
Chen G; Wu J; Li N; Guo M
Anal Bioanal Chem; 2018 Jun; 410(15):3587-3595. PubMed ID: 29476234
[TBL] [Abstract][Full Text] [Related]
10. Discovery of cyclooxygenase inhibitors from medicinal plants used to treat inflammation.
Cao H; Yu R; Choi Y; Ma ZZ; Zhang H; Xiang W; Lee DY; Berman BM; Moudgil KD; Fong HH; van Breemen RB
Pharmacol Res; 2010 Jun; 61(6):519-24. PubMed ID: 20188172
[TBL] [Abstract][Full Text] [Related]
11. In vitro inhibition of the transcription factor NF-κB and cyclooxygenase by bamboo extracts.
Van Hoyweghen L; De Bosscher K; Haegeman G; Deforce D; Heyerick A
Phytother Res; 2014 Feb; 28(2):224-30. PubMed ID: 23559516
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis, modeling studies and biological evaluation of thiazolidine derivatives containing pyrazole core as potential anti-diabetic PPAR-γ agonists and anti-inflammatory COX-2 selective inhibitors.
Abdellatif KRA; Fadaly WAA; Kamel GM; Elshaier YAMM; El-Magd MA
Bioorg Chem; 2019 Feb; 82():86-99. PubMed ID: 30278282
[TBL] [Abstract][Full Text] [Related]
13. Bioactivity-integrated ultra-performance liquid chromatography/quadrupole time-of-flight mass spectrometry for the identification of nuclear factor-κB inhibitors and β2 adrenergic receptor agonists in Chinese medicinal preparation Chuanbeipipa dropping pills.
Dong L; Luo Y; Cheng B; Zhang Y; Zhang N; Hou Y; Jiang M; Luo G; Bai G
Biomed Chromatogr; 2013 Aug; 27(8):960-7. PubMed ID: 23483566
[TBL] [Abstract][Full Text] [Related]
14. Synthesis, cyclooxygenase inhibition, anti-inflammatory evaluation and ulcerogenic liability of new 1,3,5-triarylpyrazoline and 1,5-diarylpyrazole derivatives as selective COX-2 inhibitors.
Abdellatif KRA; Abdelall EKA; Fadaly WAA; Kamel GM
Bioorg Med Chem Lett; 2016 Jan; 26(2):406-412. PubMed ID: 26691756
[TBL] [Abstract][Full Text] [Related]
15. Ethanol extract from a Chinese herbal formula, "Zuojin Pill", inhibit the expression of inflammatory mediators in lipopolysaccharide-stimulated RAW 264.7 mouse macrophages.
Wang QS; Cui YL; Dong TJ; Zhang XF; Lin KM
J Ethnopharmacol; 2012 May; 141(1):377-85. PubMed ID: 22414473
[TBL] [Abstract][Full Text] [Related]
16. [Study on chemical components in yiqing capsule based on UPLC-ESI-MS-MS and FTIR and its anti-inflammatory activity in vitro].
Luo L; Wang SM
Zhong Yao Cai; 2013 Apr; 36(4):654-7. PubMed ID: 24134016
[TBL] [Abstract][Full Text] [Related]
17. LC-MS/MS analysis and evaluation of the anti-inflammatory activity of components from BushenHuoxue decoction.
Sun D; Yan Q; Xu X; Shen W; Xu C; Tan J; Zhang H; Li L; Cheng H
Pharm Biol; 2017 Dec; 55(1):937-945. PubMed ID: 28164729
[TBL] [Abstract][Full Text] [Related]
18. Screening bioactive quality control markers of QiShenYiQi dripping pills based on the relationship between the ultra-high performance liquid chromatography fingerprint and vascular protective activity.
Zhuo L; Peng J; Zhao Y; Li D; Xie X; Tong L; Yu Z
J Sep Sci; 2017 Oct; 40(20):4076-4084. PubMed ID: 28802088
[TBL] [Abstract][Full Text] [Related]
19. [Xiaojin Wan inhibits the expression of COX-2 in prostate tissues of prostatitis pain rats].
Qu XW; Zhang SW; Zhang PH; Yin J
Zhonghua Nan Ke Xue; 2008 Aug; 14(8):759-62. PubMed ID: 18817354
[TBL] [Abstract][Full Text] [Related]
20. Effects of compounds from bi-qi capsule on the expression of inflammatory mediators in lipopolysaccharide-stimulated RAW 264.7 macrophages.
Wang QS; Cui YL; Wang YF; Chi W
J Ethnopharmacol; 2011 Jul; 136(3):480-7. PubMed ID: 20558268
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
